{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T03:39:55Z","timestamp":1794627595699,"version":"4.9.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T00:00:00Z","timestamp":1774396800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":6,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82460838"],"award-info":[{"award-number":["82460838"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Acute erythroleukemia (AEL) is a rare and highly aggressive subtype of acute myeloid leukemia (AML) that is often accompanied by splenomegaly in some patients. Using the Friend murine leukemia virus clone 57 (F-MuLV clone 57) mouse model, we observed lactate accumulation in the spleens of mice with late-stage disease. Proteomic profiling indicated dysregulation of the glycolysis\/gluconeogenesis pathway and aberrant activity of its key enzymes. In vitro, lactate alone directly induced macrophage polarization to the pro-inflammatory M1 phenotype. This lactate-rich milieu reprograms macrophage function, favoring M1 polarization. A self-reinforcing cycle thus emerges in the AEL splenic microenvironment: lactate drives M1 polarization, and these M1 macrophages subsequently elevate their glycolytic activity, amplifying local lactate production that further promotes M1 polarization. In vivo, pharmacological inhibition of lactate production with Oxamate disrupted this cycle, reversed pathogenic M1 polarization, ameliorated splenomegaly, and extended survival. These results identify lactate as a key immunomodulatory factor in the splenic microenvironment that accelerates AEL progression. Targeting this lactate-driven metabolic-immune axis represents a novel adjunctive strategy for mitigating splenomegaly and disease progression in AEL.<\/jats:p>","DOI":"10.1038\/s41419-026-08612-5","type":"journal-article","created":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T09:39:49Z","timestamp":1774431589000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Lactate-mediated macrophage polarization promotes splenomegaly in acute erythroleukemia"],"prefix":"10.1038","volume":"17","author":[{"given":"Mingyue","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanlong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suwen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongqian","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sha","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningning","family":"Zan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0394-240X","authenticated-orcid":false,"given":"Shengwen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3418-5739","authenticated-orcid":false,"given":"Heng","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,25]]},"reference":[{"key":"8612_CR1","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1182\/blood.2019003062","volume":"136","author":"A Fagnan","year":"2020","unstructured":"Fagnan A, Bagger FO, Piqu\u00e9-Borr\u00e0s M-R, Ignacimouttou C, Caulier A, Lopez CK, et al. Human erythroleukemia genetics and transcriptomes identify master transcription factors as functional disease drivers. Blood. 2020;136:698\u2013714.","journal-title":"Blood"},{"key":"8612_CR2","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.blre.2017.09.002","volume":"32","author":"P Boddu","year":"2018","unstructured":"Boddu P, Benton CB, Wang W, Borthakur G, Khoury JD, Pemmaraju N. Erythroleukemia-historical perspectives and recent advances in diagnosis and management. Blood Rev. 2018;32:96\u2013105.","journal-title":"Blood Rev"},{"key":"8612_CR3","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.clml.2023.04.011","volume":"23","author":"C Alexander","year":"2023","unstructured":"Alexander C. A History and current understanding of acute erythroid leukemia. Clin Lymphoma Myeloma Leuk. 2023;23:583\u20138.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"8612_CR4","doi-asserted-by":"publisher","first-page":"2614","DOI":"10.1038\/s41375-024-02394-5","volume":"38","author":"W Zhang","year":"2024","unstructured":"Zhang W, Yamamoto K, Chang Y-H, Yabushita T, Hao Y, Shimura R, et al. HDAC7 is a potential therapeutic target in acute erythroid leukemia. Leukemia. 2024;38:2614\u2013227.","journal-title":"Leukemia"},{"key":"8612_CR5","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.cancergen.2023.08.004","volume":"278\u2013279","author":"Y-W Qian","year":"2023","unstructured":"Qian Y-W, Wang ES, Sait SJ, Glenn ST. Acute myeloid leukemia with LRRFIP1::FGFR1 rearrangement and a complex karyotype. Cancer Genet. 2023;278\u2013279:50\u20134.","journal-title":"Cancer Genet"},{"key":"8612_CR6","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.bjhh.2014.05.006","volume":"36","author":"GC De Santis","year":"2014","unstructured":"De Santis GC, Oliveira LC, Ramos AF, da Silva NDF, Falc\u00e3o RP. Pathologic rupture of the spleen in a patient with acute myelogenous leukemia and leukostasis. Rev Bras Hematol Hemoter. 2014;36:290\u20132.","journal-title":"Rev Bras Hematol Hemoter"},{"key":"8612_CR7","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s002770050245","volume":"73","author":"AA Giagounidis","year":"1996","unstructured":"Giagounidis AA, Burk M, Meckenstock G, Koch AJ, Schneider W. Pathologic rupture of the spleen in hematologic malignancies: two additional cases. Ann Hematol. 1996;73:297\u2013302.","journal-title":"Ann Hematol"},{"key":"8612_CR8","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1002\/bjs.6737","volume":"96","author":"P Renzulli","year":"2009","unstructured":"Renzulli P, Hostettler A, Schoepfer AM, Gloor B, Candinas D. Systematic review of atraumatic splenic rupture. Br J Surg. 2009;96:1114\u201321.","journal-title":"Br J Surg"},{"key":"8612_CR9","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.5858\/2009-0350-RA.1","volume":"134","author":"Z Zuo","year":"2010","unstructured":"Zuo Z, Polski JM, Kasyan A, Medeiros LJ. Acute erythroid leukemia. Arch Pathol Lab Med. 2010;134:1261\u201370.","journal-title":"Arch Pathol Lab Med"},{"key":"8612_CR10","doi-asserted-by":"publisher","first-page":"e59","DOI":"10.1016\/S2352-3026(22)00330-1","volume":"10","author":"N Polverelli","year":"2023","unstructured":"Polverelli N, Hern\u00e1ndez-Boluda JC, Czerw T, Barbui T, D\u2019Adda M, Deeg HJ, et al. Splenomegaly in patients with primary or secondary myelofibrosis who are candidates for allogeneic hematopoietic cell transplantation: a Position Paper on behalf of the Chronic Malignancies Working Party of the EBMT. Lancet Haematol. 2023;10:e59\u2013e70.","journal-title":"Lancet Haematol"},{"key":"8612_CR11","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/0092-8674(91)90428-2","volume":"66","author":"Y Ben-David","year":"1991","unstructured":"Ben-David Y, Bernstein A. Friend virus-induced erythroleukemia and the multistage nature of cancer. Cell. 1991;66:831\u20134.","journal-title":"Cell"},{"key":"8612_CR12","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1038\/leu.2009.20","volume":"23","author":"J-W Cui","year":"2009","unstructured":"Cui J-W, Vecchiarelli-Federico LM, Li Y-J, Wang G-J, Ben-David Y. Continuous Fli-1 expression plays an essential role in the proliferation and survival of F-MuLV-induced erythroleukemia and human erythroleukemia. Leukemia. 2009;23:1311\u20139.","journal-title":"Leukemia"},{"key":"8612_CR13","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/0092-8674(82)90141-6","volume":"31","author":"T Shibuya","year":"1982","unstructured":"Shibuya T, Mak TW. Host control of susceptibility to erythroleukemia and to the types of leukemia induced by Friend murine leukemia virus: initial and late stages. Cell. 1982;31:483\u201393.","journal-title":"Cell"},{"key":"8612_CR14","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1182\/blood-2009-10-250217","volume":"116","author":"GK Lakhanpal","year":"2010","unstructured":"Lakhanpal GK, Vecchiarelli-Federico LM, Li Y-J, Cui J-W, Bailey ML, Spaner DE, et al. The inositol phosphatase SHIP-1 is negatively regulated by Fli-1 and its loss accelerates leukemogenesis. Blood. 2010;116:428\u201336.","journal-title":"Blood"},{"key":"8612_CR15","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/0092-8674(86)90800-7","volume":"47","author":"M Sitbon","year":"1986","unstructured":"Sitbon M, Sola B, Evans L, Nishio J, Hayes SF, Nathanson K, et al. Hemolytic anemia and erythroleukemia, two distinct pathogenic effects of Friend MuLV: mapping of the effects to different regions of the viral genome. Cell. 1986;47:851\u20139.","journal-title":"Cell"},{"key":"8612_CR16","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1128\/jvi.46.3.718-725.1983","volume":"46","author":"A Oliff","year":"1983","unstructured":"Oliff A, Ruscetti S. A 2.4-kilobase-pair fragment of the Friend murine leukemia virus genome contains the sequences responsible for friend murine leukemia virus-induced erythroleukemia. J Virol. 1983;46:718\u201325.","journal-title":"J Virol"},{"key":"8612_CR17","doi-asserted-by":"publisher","first-page":"e558","DOI":"10.1097\/HS9.0000000000000558","volume":"5","author":"A Fagnan","year":"2021","unstructured":"Fagnan A, Piqu\u00e9-Borr\u00e0s M-R, Tauchmann S, Mercher T, Schwaller J. Molecular landscapes and models of acute erythroleukemia. Hemasphere. 2021;5:e558.","journal-title":"Hemasphere"},{"key":"8612_CR18","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s00018-022-04160-1","volume":"79","author":"Y Ben-David","year":"2022","unstructured":"Ben-David Y, Gajendran B, Sample KM, Zacksenhaus E. Current insights into the role of Fli-1 in hematopoiesis and malignant transformation. Cell Mol Life Sci. 2022;79:163.","journal-title":"Cell Mol Life Sci"},{"key":"8612_CR19","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan D. Hallmarks of cancer: new dimensions. Cancer Discov. 2022;12:31\u201346.","journal-title":"Cancer Discov"},{"key":"8612_CR20","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1182\/blood.2022018092","volume":"141","author":"SK Mishra","year":"2023","unstructured":"Mishra SK, Millman SE, Zhang L. Metabolism in acute myeloid leukemia: mechanistic insights and therapeutic targets. Blood. 2023;141:1119\u201335.","journal-title":"Blood"},{"key":"8612_CR21","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1182\/blood-2014-02-554204","volume":"124","author":"W-L Chen","year":"2014","unstructured":"Chen W-L, Wang J-H, Zhao A-H, Xu X, Wang Y-H, Chen T-L, et al. A distinct glucose metabolism signature of acute myeloid leukemia with prognostic value. Blood. 2014;124:1645\u201354.","journal-title":"Blood"},{"key":"8612_CR22","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1189\/jlb.0710417","volume":"89","author":"PM Herst","year":"2011","unstructured":"Herst PM, Howman RA, Neeson PJ, Berridge MV, Ritchie DS. The level of glycolytic metabolism in acute myeloid leukemia blasts at diagnosis is prognostic for clinical outcome. J Leukoc Biol. 2011;89:51\u20135.","journal-title":"J Leukoc Biol"},{"key":"8612_CR23","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1126\/science.1160809","volume":"324","author":"MG Vander Heiden","year":"2009","unstructured":"Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science. 2009;324:1029\u201333.","journal-title":"Science"},{"key":"8612_CR24","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41577-020-0406-2","volume":"21","author":"M Certo","year":"2021","unstructured":"Certo M, Tsai C-H, Pucino V, Ho P-C, Mauro C. Lactate modulation of immune responses in inflammatory versus tumour microenvironments. Nat Rev Immunol. 2021;21:151\u201361.","journal-title":"Nat Rev Immunol"},{"key":"8612_CR25","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/s41392-022-01151-3","volume":"7","author":"X Li","year":"2022","unstructured":"Li X, Yang Y, Zhang B, Lin X, Fu X, An Y, et al. Lactate metabolism in human health and disease. Signal Transduct Target Ther. 2022;7:305.","journal-title":"Signal Transduct Target Ther"},{"key":"8612_CR26","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s41586-019-1678-1","volume":"574","author":"D Zhang","year":"2019","unstructured":"Zhang D, Tang Z, Huang H, Zhou G, Cui C, Weng Y, et al. Metabolic regulation of gene expression by histone lactylation. Nature. 2019;574:575\u201380.","journal-title":"Nature"},{"key":"8612_CR27","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1158\/1535-7163.MCT-07-0482","volume":"7","author":"B Clem","year":"2008","unstructured":"Clem B, Telang S, Clem A, Yalcin A, Meier J, Simmons A, et al. Small-molecule inhibition of 6-phosphofructo-2-kinase activity suppresses glycolytic flux and tumor growth. Mol Cancer Ther. 2008;7:110\u201320.","journal-title":"Mol Cancer Ther"},{"key":"8612_CR28","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1158\/0008-5472.CAN-23-0291","volume":"84","author":"AJ Monteith","year":"2024","unstructured":"Monteith AJ, Ramsey HE, Silver AJ, Brown D, Greenwood D, Smith BN, et al. Lactate utilization enables metabolic escape to confer resistance to BET inhibition in acute myeloid leukemia. Cancer Res. 2024;84:1101\u201314.","journal-title":"Cancer Res"},{"key":"8612_CR29","doi-asserted-by":"publisher","first-page":"3675","DOI":"10.1182\/blood.V96.12.3675","volume":"96","author":"PA Ney","year":"2000","unstructured":"Ney PA, D\u2019Andrea AD. Friend erythroleukemia revisited. Blood. 2000;96:3675\u201380.","journal-title":"Blood"},{"key":"8612_CR30","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.cmet.2024.10.015","volume":"37","author":"R Zhu","year":"2025","unstructured":"Zhu R, Ye X, Lu X, Xiao L, Yuan M, Zhao H, et al. ACSS2 acts as a lactyl-CoA synthetase and couples KAT2A to function as a lactyltransferase for histone lactylation and tumor immune evasion. Cell Metab. 2025;37:361\u2013.e7.","journal-title":"Cell Metab"},{"key":"8612_CR31","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.semcancer.2022.11.007","volume":"87","author":"D Sharma","year":"2022","unstructured":"Sharma D, Singh M, Rani R. Role of LDH in tumor glycolysis: regulation of LDHA by small molecules for cancer therapeutics. Semin. Cancer Biol. 2022;87:184\u201395.","journal-title":"Semin. Cancer Biol"},{"key":"8612_CR32","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s40170-016-0145-9","volume":"4","author":"AM Otto","year":"2016","unstructured":"Otto AM. Warburg effect(s)\u2014a biographical sketch of Otto Warburg and his impacts on tumor metabolism. Cancer Metab. 2016;4:5.","journal-title":"Cancer Metab"},{"key":"8612_CR33","doi-asserted-by":"publisher","first-page":"6425","DOI":"10.1002\/jcp.26429","volume":"233","author":"A Shapouri-Moghaddam","year":"2018","unstructured":"Shapouri-Moghaddam A, Mohammadian S, Vazini H, Taghadosi M, Esmaeili S-A, Mardani F, et al. Macrophage plasticity, polarization, and function in health and disease. J Cell Physiol. 2018;233:6425\u201340.","journal-title":"J Cell Physiol"},{"key":"8612_CR34","first-page":"420","volume":"5","author":"S Galv\u00e1n-Pe\u00f1a","year":"2014","unstructured":"Galv\u00e1n-Pe\u00f1a S, O\u2019Neill LAJ. Metabolic reprograming in macrophage polarization. Front Immunol. 2014;5:420.","journal-title":"Front Immunol"},{"key":"8612_CR35","doi-asserted-by":"publisher","first-page":"eaau6085","DOI":"10.1126\/sciimmunol.aau6085","volume":"4","author":"SM Lewis","year":"2019","unstructured":"Lewis SM, Williams A, Eisenbarth SC. Structure and function of the immune system in the spleen. Sci Immunol. 2019;4:eaau6085.","journal-title":"Sci Immunol"},{"key":"8612_CR36","doi-asserted-by":"publisher","first-page":"756","DOI":"10.3390\/genes13050756","volume":"13","author":"S Eshghjoo","year":"2022","unstructured":"Eshghjoo S, Kim DM, Jayaraman A, Sun Y, Alaniz RC. Macrophage polarization in atherosclerosis. Genes. 2022;13:756.","journal-title":"Genes"},{"key":"8612_CR37","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3109\/10428194.2013.796060","volume":"55","author":"AM Zeidan","year":"2014","unstructured":"Zeidan AM, Mitchell M, Khatri R, Itani D, Boikos S, Bose S, et al. Spontaneous splenic rupture during induction chemotherapy for acute myeloid leukemia. Leuk Lymphoma. 2014;55:209\u201312.","journal-title":"Leuk Lymphoma"},{"key":"8612_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-025-00833-8","volume":"13","author":"F Tarantini","year":"2025","unstructured":"Tarantini F, Coccaro N, Cumbo C, Redavid I, Anelli L, Zagaria A, et al. Splenomegaly in de novo acute myeloid leukemia is associated with ASXL1 mutations together with a distinct clinical and gene expression profile. Biomark Res. 2025;13:131.","journal-title":"Biomark Res"},{"key":"8612_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-13-101","volume":"13","author":"H Girgis","year":"2014","unstructured":"Girgis H, Masui O, White NM, Scorilas A, Rotondo F, Seivwright A, et al. Lactate dehydrogenase A is a potential prognostic marker in clear cell renal cell carcinoma. Mol Cancer. 2014;13:101.","journal-title":"Mol Cancer"},{"key":"8612_CR40","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/s41571-022-00686-2","volume":"19","author":"G Claps","year":"2022","unstructured":"Claps G, Faouzi S, Quidville V, Chehade F, Shen S, Vagner S, et al. The multiple roles of LDH in cancer. Nat Rev Clin Oncol. 2022;19:749\u201362.","journal-title":"Nat Rev Clin Oncol"},{"key":"8612_CR41","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3389\/fonc.2018.00081","volume":"8","author":"A Morrot","year":"2018","unstructured":"Morrot A, da Fonseca LM, Salustiano EJ, Gentile LB, Conde L, Filardy AA, et al. Metabolic symbiosis and immunomodulation: how tumor cell-derived lactate may disturb innate and adaptive immune responses. Front Oncol. 2018;8:81.","journal-title":"Front Oncol"},{"key":"8612_CR42","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/nri3175","volume":"12","author":"DI Gabrilovich","year":"2012","unstructured":"Gabrilovich DI, Ostrand-Rosenberg S, Bronte V. Coordinated regulation of myeloid cells by tumours. Nat Rev Immunol. 2012;12:253\u201368.","journal-title":"Nat Rev Immunol"},{"key":"8612_CR43","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.cmet.2016.08.011","volume":"24","author":"A Brand","year":"2016","unstructured":"Brand A, Singer K, Koehl GE, Kolitzus M, Schoenhammer G, Thiel A, et al. LDHA-associated lactic acid production blunts tumor immunosurveillance by T and NK cells. Cell Metab. 2016;24:657\u201371.","journal-title":"Cell Metab"},{"key":"8612_CR44","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.4049\/jimmunol.1202702","volume":"191","author":"Z Husain","year":"2013","unstructured":"Husain Z, Huang Y, Seth P, Sukhatme VP. Tumor-derived lactate modifies antitumor immune response: effect on myeloid-derived suppressor cells and NK cells. J Immunol. 2013;191:1486\u201395.","journal-title":"J Immunol"},{"key":"8612_CR45","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nature13490","volume":"513","author":"OR Colegio","year":"2014","unstructured":"Colegio OR, Chu N-Q, Szabo AL, Chu T, Rhebergen AM, Jairam V, et al. Functional polarization of tumour-associated macrophages by tumour-derived lactic acid. Nature. 2014;513:559\u201363.","journal-title":"Nature"},{"key":"8612_CR46","doi-asserted-by":"publisher","first-page":"3632","DOI":"10.1158\/0008-5472.CAN-16-2938","volume":"77","author":"P Seth","year":"2017","unstructured":"Seth P, Csizmadia E, Hedblom A, Vuerich M, Xie H, Li M, et al. Deletion of lactate dehydrogenase-A in myeloid cells triggers antitumor immunity. Cancer Res. 2017;77:3632\u201343.","journal-title":"Cancer Res"},{"key":"8612_CR47","doi-asserted-by":"publisher","first-page":"9030","DOI":"10.1074\/jbc.M511397200","volume":"281","author":"MS Ullah","year":"2006","unstructured":"Ullah MS, Davies AJ, Halestrap AP. The plasma membrane lactate transporter MCT4, but not MCT1, is up-regulated by hypoxia through a HIF-1alpha-dependent mechanism. J Biol Chem. 2006;281:9030\u20137.","journal-title":"J Biol Chem"},{"key":"8612_CR48","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.tcb.2017.11.006","volume":"28","author":"AJ Wolpaw","year":"2018","unstructured":"Wolpaw AJ, Dang CV. Exploiting metabolic vulnerabilities of cancer with precision and accuracy. Trends Cell Biol. 2018;28:201\u201312.","journal-title":"Trends Cell Biol"},{"key":"8612_CR49","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.621458","volume":"10","author":"E Saulle","year":"2020","unstructured":"Saulle E, Spinello I, Quaranta MT, Pasquini L, Pelosi E, Iorio E, et al. Targeting lactate metabolism by inhibiting MCT1 or MCT4 impairs leukemic cell proliferation, induces two different related death-pathways and increases chemotherapeutic sensitivity of acute myeloid leukemia cells. Front Oncol. 2020;10:621458.","journal-title":"Front Oncol"},{"key":"8612_CR50","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1158\/0008-5472.CAN-24-0019","volume":"84","author":"E Bo\u00ebt","year":"2024","unstructured":"Bo\u00ebt E, Sarry J-E. Targeting metabolic dependencies fueling the TCA cycle to circumvent therapy resistance in acute myeloid leukemia. Cancer Res. 2024;84:950\u20132.","journal-title":"Cancer Res"},{"key":"8612_CR51","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1128\/jvi.33.1.475-486.1980","volume":"33","author":"AI Oliff","year":"1980","unstructured":"Oliff AI, Hager GL, Chang EH, Scolnick EM, Chan HW, Lowy DR. Transfection of molecularly cloned Friend murine leukemia virus DNA yields a highly leukemogenic helper-independent type C virus. J Virol. 1980;33:475\u201386.","journal-title":"J Virol"},{"key":"8612_CR52","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1073\/pnas.87.4.1332","volume":"87","author":"Y Ben-David","year":"1990","unstructured":"Ben-David Y, Giddens EB, Bernstein A. Identification and mapping of a common proviral integration site Fli-1 in erythroleukemia cells induced by Friend murine leukemia virus. Proc Natl Acad Sci USA. 1990;87:1332\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8612_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2011.52","volume":"2","author":"Y-J Li","year":"2012","unstructured":"Li Y-J, Zhao X, Vecchiarelli-Federico LM, Li Y, Datti A, Cheng Y, et al. Drug-mediated inhibition of Fli-1 for the treatment of leukemia. Blood Cancer J. 2012;2:e54.","journal-title":"Blood Cancer J"},{"key":"8612_CR54","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1074\/mcp.M400129-MCP200","volume":"3","author":"PL Ross","year":"2004","unstructured":"Ross PL, Huang YN, Marchese JN, Williamson B, Parker K, Hattan S, et al. Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol Cell Proteom. 2004;3:1154\u201369.","journal-title":"Mol Cell Proteom"},{"key":"8612_CR55","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25:402\u20138.","journal-title":"Methods"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08612-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08612-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08612-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T21:01:55Z","timestamp":1774990915000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08612-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,25]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8612"],"URL":"https:\/\/doi.org\/10.1038\/s41419-026-08612-5","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,25]]},"assertion":[{"value":"29 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All experiment involving animals were ethically reviewed and approved by Experimental Animal Ethics Committee, Guizhou Medical University (No. 2500302) under Animal Production License No. SYXK (Gui) 2025-0001.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"373"}}